Clinical Trial

A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)

Study acronym: MY MYELOMA
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this observational study is the creation of a national multiple myeloma registry to monitor the current routine clinical practice in Italy and describe the standard of care adopted for the diagnosis and treatment of patients with multiple myeloma in the different Italian hematology centers.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-08-06; most recent amendment 2025-02-25.
Trial Details
NCT Number NCT05001087
Lead Sponsor Fondazione EMN Italy Onlus
Collaborators: Amgen, GlaxoSmithKline, Janssen-Cilag S.p.A., Sanofi, Takeda, Bristol-Myers Squibb
Conditions Multiple Myeloma
Enrollment 1,900 participants
Start Date 2021-03-16
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-27